SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-040599
Filing Date
2024-03-28
Accepted
2024-03-28 17:01:15
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm249930d1_s3.htm S-3 353351
2 EXHIBIT 4.2 tm249930d1_ex4-2.htm EX-4.2 361920
3 EXHIBIT 4.4 tm249930d1_ex4-4.htm EX-4.4 111683
4 EXHIBIT 4.5 tm249930d1_ex4-5.htm EX-4.5 119265
5 EXHIBIT 4.6 tm249930d1_ex4-6.htm EX-4.6 103325
6 EXHIBIT 5.1 tm249930d1_ex5-1.htm EX-5.1 28839
7 EXHIBIT 23.1 tm249930d1_ex23-1.htm EX-23.1 2449
8 EX-FILING FEES tm249930d1_ex-filingfees.htm EX-FILING FEES 44850
9 GRAPHIC tm249930d1_s3img001.jpg GRAPHIC 14297
10 GRAPHIC tm249930d1_ex5-1img001.jpg GRAPHIC 4796
  Complete submission text file 0001104659-24-040599.txt   1153469
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-278340 | Film No.: 24800139
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)